✦ LIBER ✦

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

✍ Scribed by Gunter von Minckwitz, Sebastian Harder, Sascha Hövelmann…

Book ID: 120699990
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 326 KB
Volume: 7
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr1264

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correction: Phase I clinical study of th

Correction: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

✍ Gunter von Minckwitz, Sebastian Harder, Sascha Hövelmann… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 33 KB

Phase I Pharmacokinetic and Pharmacodyna

Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors

✍ Paz-Ares, L. G.; Gomez-Roca, C.; Delord, J.-P.; Cervantes, A.; Markman, B.; Corr 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB